Atossa Therapeutics (ATOS) enters reverse-split Monday as Nasdaq compliance clock tightens
Atossa Therapeutics, Inc. is set to implement a one-for-fifteen reverse stock split on Monday, according to a Nasdaq notice. Following the split, the shares will trade under a new CUSIP in the U.S. securities system.